Please login to the form below

Not currently logged in
Email:
Password:

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.

Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.

Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.

She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.

Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.

“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.

Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

1st May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics